Center for Disease Resistance

Objective 1: Investigate the mechanisms underlying a disease, and microbial resistance to antibiotics, antivirals, and other therapeutics.

​

Objective 2: Develop predictive models to anticipate the emergence and spread of drug-resistant mechanisms, and pathogens.

​

Objective 3: Investigate alternative approaches to combat drug resistance, such as combination therapies or novel drug targets.

Center for Advanced Diagnostics

Objective 1: Develop innovative diagnostic tools and techniques for rapid and accurate detection of infectious diseases, type 2 diabetes, cancer, and neurodegenerative diseases.

​

Objective 2: Validate and optimize diagnostic assays through rigorous testing and clinical studies.

​

Objective 3: Implement point-of-care diagnostic solutions for resource-limited settings, improving access to healthcare globally.

Center for Therapeutic Innovation

Objective 1: Identify novel targets for drug discovery through computational modeling, drug repurposing, and bioinformatics analyses.

​

Objective 2: Facilitate preclinical and clinical evaluation of promising therapeutics for infectious diseases, type 2 diabetes, cancer, and neurodegenerative diseases.

​

Objective 3: Optimize treatment regimens and dosage strategies to enhance efficacy and minimize resistance development.

Center for Climatic

Health

Objective 1: Investigate the impact of climate change on disease transmission dynamics and vector ecology.

​

Objective 2: Develop predictive models to assess the vulnerability of populations to climate-sensitive diseases.

​

Objective 3: Collaborate with climate scientists and policymakers to develop adaptation strategies and mitigate health risks associated with changing climates.